Author:
Okada Ken-ichi,Kawai Manabu,Hirono Seiko,Miyazawa Motoki,Kitahata Yuji,Ueno Masaki,Hayami Shinya,Ikoma Akira,Sonomura Tetsuo,Wan Ke,Shimokawa Toshio,Yamaue Hiroki
Reference29 articles.
1. Wellner UF, Shen Y, Keck T, Jin W, Xu Z. The survival outcome and prognostic factors for distal cholangiocarcinoma following surgical resection: a meta-analysis for the 5-year survival. Surg Today. 2017;47:271-279.
2. Clements O, Eliahoo J, Kim JU, Taylor-Robinson SD, Khan SA. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis. J Hepatol. 2020;72:95-103.
3. Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: Epidemiology and risk factors. Liver Int. 2019;39 Suppl 1:19-31.
4. National Comprehensive Cancer Network. NCCN practice guidelines for hepatobiliary cancer, version 3. 2021 Available at: https://www.nccn.org/professionals/physician_gls/pdf/hepatobiliary.pdf. Accessed June 28, 2021.
5. Kang JS, Lee S, Son D, Han Y, Lee KB, Kim JR, Kwon W, Kim SW, Jang JY. Prognostic predictability of the new American Joint Committee on Cancer 8th staging system for distal bile duct cancer: limited usefulness compared with the 7th staging system. J Hepatobiliary Pancreat Sci. 2018;25:124-130.